Hyrax Biosciences is an award-winning genetic software company that takes the complexity out of sequence data analysis for companies around the world. Our automated platform, Exatype, a leading bioinformatics software platform, combines scalable tech and unique algorithms to deliver detailed and accurate genotype reports, without the need for human intervention or the threat of human error.
We believe that the greatest opportunity for breakthrough medical discoveries lives in the space where human science and computer science meet - and Exatype is the result of that belief. With an ever-expanding suite of disease-specific plug-ins, this single, comprehensive genomics software platform has the capacity to run any genetic test on any disease, delivering consistently accurate and clear reporting in any desired format.
We are driven by one overriding goal: To create a single software platform that can run any genetic test on any disease, and deliver a consistently accurate and clear report.
Simon is an expert in computational biology and bioinformatics, specialising in molecular evolution. Backed by 15 years of experience in bioinformatics, his widely published research focuses on the development and application of highly sensitive bioinformatics approaches to various aspects of HIV, including drug resistance, molecular epidemiology and vaccines.
Natasha has a multifaceted background across industries. She gained experience in academia as lecturer and group leader in computational biology, within IP law as a candidate patent attorney, and also in biotech as an application specialist at Roche. She is passionate about global health and impactful, translational innovation.
Kirsten is a medical doctor with broad-based experience in healthcare management and innovation. She practised in various public-sector hospitals in South Africa and the UK before spending 5 years as a life science and healthcare sector consultant at Accenture and PA Consulting in London. Most recently, she managed the mobile health portfolio at Vodacom.
Andre has over 28 years experience working in software development in both the corporate and startup environments. This means that he translates his knowledge effectively and efficiently and has a keen eye for anticipating and preparing for the future. He remains passionate about software development, architecture and process improvement.
Dylan has been a Director of Hyrax Biosciences since 2017. As the co-founder of Vertica Health – a digital health company that develops medical observation solutions – as well as business consulting company Change Dimensions, he brings a wealth of knowledge and experience to the team.